- Home
- MLAB vs PFN Comparison
MLAB vs PFN Comparison
Compare MLAB & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- PFN
- Stock Information
- Founded
- MLAB 1982
- PFN 2004
- Country
- MLAB United States
- PFN United States
- Employees
- MLAB N/A
- PFN N/A
- Industry
- MLAB Industrial Machinery/Components
- PFN Finance/Investors Services
- Sector
- MLAB Industrials
- PFN Finance
- Exchange
- MLAB Nasdaq
- PFN Nasdaq
- Market Cap
- MLAB 602.2M
- PFN 661.3M
- IPO Year
- MLAB N/A
- PFN N/A
- Fundamental
- Price
- MLAB $102.44
- PFN $7.41
- Analyst Decision
- MLAB Hold
- PFN
- Analyst Count
- MLAB 2
- PFN 0
- Target Price
- MLAB $140.00
- PFN N/A
- AVG Volume (30 Days)
- MLAB 39.1K
- PFN 331.7K
- Earning Date
- MLAB 11-07-2024
- PFN 01-01-0001
- Dividend Yield
- MLAB 0.62%
- PFN 11.66%
- EPS Growth
- MLAB N/A
- PFN N/A
- EPS
- MLAB N/A
- PFN N/A
- Revenue
- MLAB $228,380,000.00
- PFN N/A
- Revenue This Year
- MLAB $11.26
- PFN N/A
- Revenue Next Year
- MLAB $5.27
- PFN N/A
- P/E Ratio
- MLAB N/A
- PFN N/A
- Revenue Growth
- MLAB 6.88
- PFN N/A
- 52 Week Low
- MLAB $83.68
- PFN $5.94
- 52 Week High
- MLAB $141.17
- PFN $7.58
- Technical
- Relative Strength Index (RSI)
- MLAB 34.03
- PFN 33.57
- Support Level
- MLAB $113.26
- PFN $7.32
- Resistance Level
- MLAB $121.00
- PFN $7.60
- Average True Range (ATR)
- MLAB 5.99
- PFN 0.07
- MACD
- MLAB -1.65
- PFN -0.01
- Stochastic Oscillator
- MLAB 1.03
- PFN 32.14
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About PFN PIMCO Income Strategy Fund II
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.